Anti-Asthma / COPD
Anti-Cancer / Oncology
Antiretroviral / Anti-HIV
Erectile Dysfunction (ED)
Monoclonal Antibodies (mAbs)
Research & Development (Preclinical Lab APIs)
Clinical Phase API Supplies
Commercial Stage cGMP APIs
APIs for Drug Delivery Systems
Regulatory Support Services
Contract Research & Manufacturing Services
Press & Media
Trade Shows & Events
Search products by name or CAS#
LGM Pharma is a Sodium Alginate CAS# 9005-38-3 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, delivery, purity, and more.
Questions? Call our customer API support number 1-(800)-881-8210.
LGM Pharma offers this active ingredient but not the finished dosage forms.
AI3-19772, Algiline, Algin, Algin (Laminaria spp. and other kelps), Algin (polysaccharide), Alginate KMF, Alginic acid, sodium salt, Algipon L-1168, Amnucol, Antimigrant C 45, Cecalgine TBV, Cohasal-IH, Darid QH, Dariloid QH, Duckalgin, FEMA No. 2014, Halltex, HSDB 1909, Kelco Gel LV, Kelcosol, Kelgin, Kelgin F, Kelgin HV, Kelgin LV, Kelgin XL, Kelgum, Kelset, Kelsize, Keltex, Keltone, L'-Algiline, Lamitex, Manucol, Manucol DM, Manucol KMF, Manucol SS/LD2, Manugel F 331, Manutex, Manutex F, Manutex RS 1, Manutex RS-5, Manutex rS1, Manutex SA/KP, Manutex SH/LH, Meypralgin R/LV, Minus, Mosanon, Nouralgine, OG 1, Pectalgine, Proctin, Protacell 8, Protanal, Protatek, Snow algin H, Snow algin L, Snow algin M, Sodium alginate, Sodium polymannuronate, Stipine, Tagat, Tragaya, UNII-C269C4G2ZQ
Typically NLT 98%
Mode of Action:
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.
API’s From Quality Manufacturers:
Cost effective materials based on specific requirements
Small quantities for initial research and larger development quantities towards product commercialization
Technical packages, letters of access to filed DMFs
Complete assistance in any regulatory filings
Top quality GMP certified manufacturers
Have necessary regulatory credentials
Related Blog Post
FDA Agrees to Priority Review of Sumatriptan and Naproxen…
Related YouTube Videos